About: Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $3.70 (+9.14%)
UPB NASDAQ Upstream Bio, Inc.
Upstream Bio, Inc. share price
UPB price activity
Last Price
$3.700
Change (24hr)
0.31 USD (9.14%)
Volume
1.25M
Volume (4w avg)
-
Open
$3.59
Day Range
$3.52 - $3.84
Previous Close
$3.39
Last Trade
04 Nov, 9:00 pm GMT+0
Delayed
04 Nov, 9:00 pm GMT+0
UPB price performance
Delayed
04 Nov, 9:00 pm GMT+0
UPB details
UPB Market Signals